FOR IMMEDIATE RELEASE | IKON Group Investments | Houston, Texas | media@ikongroupinvestments.com
Kynetide Peptides Expands Product Line with Three New Performance Formulations
Kynetide Peptides launches three new peptide-based performance and recovery formulations backed by extensive clinical research. IKON Group Investments continues to build a world-class global holding company from its Houston, Texas headquarters, deploying patient capital and operational partnership to create extraordinary value for stakeholders.
For more information about IKON Group Investments and our portfolio, visit ikongroupinvestments.com or contact us at investors@ikongroupinvestments.com.
###